This possibly reflects a higher cancer cell burden in liquid tumours that may lead to higher cystatin C levels,34 suggesting that there is a complex relationship between serum biomarkers and individual disease states, and future studies are needed to best individualize GFR estimation in patients with cancer. This evidence concerns the gene CST3 and neoplasm.